1. Home
  2. FNWD vs SIGA Comparison

FNWD vs SIGA Comparison

Compare FNWD & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$43.66

Market Cap

187.1M

Sector

Finance

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$3.13

Market Cap

223.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
SIGA
Founded
1994
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
223.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
FNWD
SIGA
Price
$43.66
$3.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.7K
★ 549.9K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
1.10%
★ 19.05%
EPS Growth
★ N/A
N/A
EPS
★ 1.00
0.13
Revenue
N/A
N/A
Revenue This Year
$10.81
N/A
Revenue Next Year
$5.26
$170.70
P/E Ratio
$43.41
★ $24.19
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$2.83
52 Week High
$45.90
$8.54

Technical Indicators

Market Signals
Indicator
FNWD
SIGA
Relative Strength Index (RSI) 61.46 44.11
Support Level $42.56 $3.02
Resistance Level $44.01 $3.32
Average True Range (ATR) 0.83 0.12
MACD 0.26 -0.02
Stochastic Oscillator 95.15 17.78

Price Performance

Historical Comparison
FNWD
SIGA

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: